Allergic eye disease mechanisms
Open Access
- 1 October 1998
- journal article
- review article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 82 (10) , 1203-1214
- https://doi.org/10.1136/bjo.82.10.1203
Abstract
Allergic eye disease is a common ocular problem. It is one part of the whole spectrum of allergic diseases which share a common initiating mechanism and a characteristic pattern of inflammation. The association between exposure to airborne plant pollens and the development of ocular and nasal symptoms in itself was noted by Charles Blackley in 1873.1 The classification of allergic eye diseases is based entirely on clinical features, which in the past has resulted in the use of inappropriate or unsatisfactory treatments, owing to our lack of knowledge of the underlying mechanisms. Recent work has defined such underlying pathogenic mechanisms of allergic eye disease, extending our knowledge of the cellular and mediator mechanisms involved, and enabling pathophysiological correlates to be made between the clinical patterns of disease and responses to treatment. This is now resulting in a clearer understanding of the disease processes which, in the long term, holds promise for the development of more effective treatments. As the prevalence of allergic disease is increasing, probably through environmental factors, it is appropriate at this stage to review our current knowledge of the mechanisms of allergic eye disease. The morbidity and mortality of asthma have increased in the past few years2-5 with no corresponding rise in the underlying rate of atopy itself.6 Environmental causes have been cited as responsible for this, as the rising trends have occurred too quickly for genetic causes to have exerted their effects.6The increase in asthma has coincided with an increase in house dust mite levels, and is greatest in communities exposed to high allergen levels.2 However, there are no firm data available on which to base any change in the incidence of allergic eye disease. The reported incidence rates for the different forms of allergic eye disease have been varied. …Keywords
This publication has 107 references indexed in Scilit:
- Immunolocalization of cytokines to mast cells in normal and allergic conjunctivaClinical and Experimental Allergy, 1997
- Evaluation of the new ophthalmic antihistamine, 0.05% levocabastine, in the clinical allergen challenge model of allergic conjunctivitisJournal of Allergy and Clinical Immunology, 1994
- Nedocromil sodium and astemizole, alone or combined, in the treatment of seasonal allergic conjunctivitisActa Ophthalmologica, 1993
- Immunohistochemistry on Resin Sections: A Comparison of Resin Embedding Techniques for Small Mucosal BiopsiesBiotechnic & Histochemistry, 1993
- LevocabastineDrugs, 1991
- Mast cell numbers and staining characteristics in the normal and allergic human conjunctivaJournal of Allergy and Clinical Immunology, 1991
- Human conjunctival mast cells: Distribution of MCT and MCTC in vernal conjunctivitis and giant papillary conjunctivitisJournal of Allergy and Clinical Immunology, 1990
- Effects of gender and sex steroids on the immune responseJournal of Steroid Biochemistry, 1990
- Effects of Sodium Cromoglycate and Nedocromil Sodium on Histamine Secretion from Mast Cells from Various LocationsDrugs, 1989
- Antibodies to grass in vernal conjunctivitisJournal of Allergy, 1963